Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Sep 01, 2022
FDA Approved IDE for Picso® Pivotal Study of Miracor Medical On August 23, 2022, Miracor Medical SA, a provider of innovative solutions for the treatment of severe cardiac diseases, announced that the FDA has approved an Investigational Device Exemption (IDE), allowing the company to begin a pivotal study with i...
Read More...
Aug 31, 2022
The rapid growth in technology and innovation are bringing new opportunities and scope for simplification in product development and process and are creating comfort and simplifying lives in their own way. The ongoing breakthroughs and innovation are leading to better outcomes/productivity, saving time, increasing ...
Read More...
Aug 25, 2022
Edwards Pascal Precision Transcatheter Mitral And Tricuspid Valve Repair System Receives CE Mark On August 17, 2022, Edwards Lifesciences Corporation, an American medical technology company headquartered in Irvine, California, specializes in artificial heart valves and hemodynamic monitoring. The company announc...
Read More...
Aug 18, 2022
CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System On August 09, 2022, CereVasc, Inc., a privately held, clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved ...
Read More...
Aug 17, 2022
In today’s highly dynamic and evolving market dynamics, interoperability plays a key role in facilitating organized and effective data exchange between information systems. Businesses across different verticals and sectors are implementing interoperability in the system to address critical issues such as duplicate ...
Read More...
Aug 11, 2022
Rapid Medical Obtains FDA Clearance for the World's Smallest and Only Adjustable Thrombectomy Device On July 26, 2022, Rapid Medical, a leading developer of advanced neurovascular devices, received Food and Drug Administration (FDA) 510(k) clearance for TIGERTRIEVER™13 for large vessel occlusions.&n...
Read More...
Jul 28, 2022
ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension On July 26, 2022, ReCor Medical, Inc., a completely owned subsidiary of Otsuka Medical Devices Co., Ltd., with its headquarters in Palo Alto,...
Read More...
Jul 20, 2022
It is estimated that around five billion people are on the verge of losing access to essential healthcare services by 2030, for example, mandatory healthcare services, necessary medicine, and visiting healthcare providers. This issue can further become complex if there is an increase in the shortage of trained heal...
Read More...
Jun 29, 2022
A software program and a hardware device that is capable of decoding a human voice is known as Voice recognition technology or Voice search technology. Voice search technology converts a spoken word into a command or text entry. Voice search is not just limited to recognizing the spoken word, it includes identifica...
Read More...
Jun 23, 2022
Conformal Medical Announces Launch of CONFORM Pivotal Trial On June 17, 2022, Conformal Medical Inc, is a medical device company manufacturing devices to avoid strokes in patients with non-valvular atrial fibrillation and developing next-generation LAAO technology. Its exclusive technology is intended to make le...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper